TY - JOUR
T1 - Malignant mixed müllerian tumor of primary mesenteric origin associated with a synchronous ovarian cancer
T2 - Case report and literature review
AU - Ma, C. J.
AU - Yang, S. F.
AU - Huang, C. C.
AU - Chai, C. Y.
AU - Cheng, K. I.
AU - Tsai, E. M.
AU - Wang, J. Y.
PY - 2008
Y1 - 2008
N2 - Malignant mixed müllerian tumor (MMMT) is a rare tumor in females and extragenital MMMT is even more so. We report a patient with MMMT primarily in the mesentery with synchronous ovarian cancer. In the English literature, 42 cases of extragenital MMMT have been reported other than the presented case, and this is only the second MMMT arising from the mesentery. Furthermore, among the cases reviewed, MMMTs tend to be associated with synchronous or metachronous colonic cancer or gynecologic tumors originating from the müllerian duct, including ovarian tumors, fallopian tube cancer, endometrial cancer, cervical cancer, and serous carcinoma of the peritoneum (14 out of 43 patients; 32.6%). The risk factors for MMMT include obesity, nulliparity, exogenous estrogen, and long-term tamoxifen use. The prognosis of MMMT is catastrophic and the treatment is based on the experience of those of uterine sarcomas, which is composed of operation, radiotherapy and chemotherapy.
AB - Malignant mixed müllerian tumor (MMMT) is a rare tumor in females and extragenital MMMT is even more so. We report a patient with MMMT primarily in the mesentery with synchronous ovarian cancer. In the English literature, 42 cases of extragenital MMMT have been reported other than the presented case, and this is only the second MMMT arising from the mesentery. Furthermore, among the cases reviewed, MMMTs tend to be associated with synchronous or metachronous colonic cancer or gynecologic tumors originating from the müllerian duct, including ovarian tumors, fallopian tube cancer, endometrial cancer, cervical cancer, and serous carcinoma of the peritoneum (14 out of 43 patients; 32.6%). The risk factors for MMMT include obesity, nulliparity, exogenous estrogen, and long-term tamoxifen use. The prognosis of MMMT is catastrophic and the treatment is based on the experience of those of uterine sarcomas, which is composed of operation, radiotherapy and chemotherapy.
KW - Malignant mixed müllerian tumor
KW - Mesentery
KW - Ovarian cancer
UR - https://www.scopus.com/pages/publications/44349184219
M3 - 文章
C2 - 18592799
AN - SCOPUS:44349184219
SN - 0392-2936
VL - 29
SP - 289
EP - 293
JO - European Journal of Gynaecological Oncology
JF - European Journal of Gynaecological Oncology
IS - 3
ER -